- Capital Cube•15 days ago
Categories: Yahoo Finance Get free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc., Albany Molecular Research, Inc. and Akorn, Inc. (MYL-US, CBM-US, ACET-US, NKTR-US, PFE-US, AMRI-US and ... Read more (Read more...)
- GlobeNewswire•17 days ago
NORTHVALE, N.J., March 13, 2017-- Elite Pharmaceuticals, Inc., announced today that it has initiated pharmacokinetic testing of its reformulated SequestOx™. The reformulated product is expected to have ...
- GlobeNewswire•2 months ago
NORTHVALE, N.J., Feb. 09, 2017-- Elite Pharmaceuticals, Inc., announced results for the quarter ended December 31, 2016, the third quarter of its 2017 fiscal year. Consolidated revenues for the third quarter ...
ELTP : Summary for ELITE PHARMA INC - Yahoo Finance
Elite Pharmaceuticals, Inc. (ELTP)
OTC BB - OTC BB Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.14 - 0.15|
|52 Week Range||0.11 - 0.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||4.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|